It will house some of the company’s most advanced equipment, which allow for AI analysis and 3D imaging, according to Dr. Yen-Yin Lin, the CEO of JelloX. “With all the promise 3D pathology ...

the high sampling capacity of 3D pathology holds particular potential," commented Dr. Yen-Yin Lin, CEO of JelloX. "JelloX Biotech's Comprehensive HER2 Diagnostic Solution is poised to ...

"Medical problems like cancer require many parties working together to create better treatments and patient care," commented Dr. Yen-Yin Lin, CEO of JelloX. "With all the promise 3D pathology ...

"For the specific challenges posed by metastatic breast cancer and the need to identify predictive biomarkers accurately, the high sampling capacity of 3D pathology holds particular potential," ...

"Medical problems like cancer require many parties working together to create better treatments and patient care," commented Dr. Yen-Yin Lin, CEO of JelloX. "With all the promise 3D pathology offers, ...